Showing results (2001-2010 of 2,394) with videos related to

Sort By:
Pageof 240
The AAPS Journal|March 29, 2023
Predicting Food Effects on Oral Extended-Release Drug Products: A Retrospective EvaluationPeng Zou, Jayabharathi Vaidyanathan, Doanh Tran, et al.
The AAPS Journal|March 28, 2023
Leveraging Prior Healthy Participant Pharmacokinetic Data to Evaluate the Impact of Renal and Hepatic Impairment on Ritlecitinib PharmacokineticsVivek Purohit, Yeamin Huh, Jessica Wojciechowski, et al.
The AAPS Journal|May 22, 2012
Physiochemical and biochemical factors influencing the pharmacokinetics of antibody therapeuticsDaniela Bumbaca, C Andrew Boswell, Paul J Fielder, et al.
The AAPS Journal|May 15, 2012
A platform for characterizing therapeutic monoclonal antibody breakdown products by 2D chromatography and top-down mass spectrometryMatthew T Mazur, Richard S Seipert, David Mahon, et al.
The AAPS Journal|April 25, 2012
Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response modelsElodie L Plan, Alan Maloney, France Mentré, et al.
The AAPS Journal|April 25, 2012
Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the AmericasRaimar Löbenberg, Nadia B Chacra, Erika S Stippler, et al.
The AAPS Journal|April 25, 2012
Pain assessment in human fetus and infantsCarlo Valerio Bellieni
The AAPS Journal|April 25, 2012
Pharmacokinetic mAb-mAb interaction: anti-VEGF mAb decreases the distribution of anti-CEA mAb into colorectal tumor xenograftsLubna Abuqayyas, Joseph P Balthasar
The AAPS Journal|May 2, 2012
Predicting the effects of anti-angiogenic agents targeting specific VEGF isoformsStacey D Finley, Aleksander S Popel
The AAPS Journal|December 23, 2011
Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonistShirin Bruderer, Päivi Aänismaa, Marie-Claude Homery, et al.
Pageof 240